MedTrace Logo

Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

NCT01459042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2011-10-25

No results posted yet for this study

Summary

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Conditions

  • Hypertension, Resistant to Conventional Therapy

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Weiqing Wang, MD, PhD · Endocrinology Department of Ruijin Hospital affiliated Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01459042 on ClinicalTrials.gov